| House Panel Probes Gene Tests A House panel is investigating personal genetic test kits currently sold over the Internet after one company proposed selling its kits through retailers. online.wsj.com |
Clarient to Announce 2010 Second Quarter and Six-Month Financial Results on Wednesday, July 28, 2010 (PR Newswire) Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it will report its financial results for the second quarter and six months ended June 30, 2010 after the stock market closes on Wednesday, July 28. Â us.rd.yahoo.com |
Amicus Therapeutics, Inc. Q2 2010 Earnings Call Transcript Amicus Therapeutics, Inc. (FOLD)Q2 2010 Earnings CallAugust 5, 2010 5:00 PM ETComplete Story » seekingalpha.com |
Dendreon Stays in Neutral Zacks.com submits: We are maintaining our Neutral recommendation on Dendreon Corporation (DNDN) with a target price of $44.00. Dendreon, founded in 1992 and headquartered in Seattle, Washington, is a biotechnology company focused on developing drugs for cancer. The company received a huge boost with the US Food and Drug Administration (FDA) approving Provenge (sipuleucel-T), a therapeutic vaccine for treating advanced prostate cancer in men.Complete Story » seekingalpha.com |
Genzyme Makes Case Against Sanofi Genzyme provided 2011 profit projections that are well above current street expectations, as it tries to thwart an $18.5 billion hostile takeover bid from Sanofi-Aventis that it believes is too low. online.wsj.com |